Patient-Derived Three-Dimensional Tumor Organoid Model for In Vitro Chimeric Antigen Receptor T Cell Screening

Area of Science:

• Oncology
• Immunotherapy
• Biotechnology

Background:

• Chimeric antigen receptor T (CAR-T) cell therapy shows promise in hematological cancers but faces challenges in solid tumors.
• Patient-derived tumor organoids offer a 3D in vitro model reflecting patient heterogeneity for drug testing.

Purpose of the Study:

• To establish and validate an in vitro efficacy testing model for CAR-T cell therapy in solid tumors using patient-derived colorectal cancer organoids.
• To assess the direct cytotoxic effects of CAR-T cells on 3D tumor organoids.

Main Methods:

• Colorectal cancer patient samples were used to generate 3D tumor organoids.
• Tumor organoids were co-cultured with CAR-T cells at varying effector-to-target (E:T) ratios.
• Morphological changes and dead cell staining were used to evaluate CAR-T cell-mediated tumor killing.

Main Results:

• The co-culture system effectively allowed observation of CAR-T cell interactions with 3D tumor organoids.
• Dead cell staining indicated the cytotoxic impact of CAR-T cells on the organoids.
• The model demonstrated the potential to assess CAR-T cell tumor-killing activity.

Conclusions:

• This co-culture model provides a viable method for evaluating CAR-T cell efficacy against patient-derived colorectal cancer organoids.
• The model facilitates the study of CAR-T cell-tumor interactions in a 3D in vitro setting.
• This approach can aid in the development of CAR-T cell therapies for solid tumors.